PL2240200T3 - Terapeutyczny peptyd zasadowego białka mieliny MBP83-99 wiążący mannan - Google Patents

Terapeutyczny peptyd zasadowego białka mieliny MBP83-99 wiążący mannan

Info

Publication number
PL2240200T3
PL2240200T3 PL09703874.9T PL09703874T PL2240200T3 PL 2240200 T3 PL2240200 T3 PL 2240200T3 PL 09703874 T PL09703874 T PL 09703874T PL 2240200 T3 PL2240200 T3 PL 2240200T3
Authority
PL
Poland
Prior art keywords
mbp83
mannan
therapeutic
linked
basic protein
Prior art date
Application number
PL09703874.9T
Other languages
English (en)
Inventor
John Matsoukas
Theodore Tselios
Vasso Apostolopoulos
Vivian Tseveleki
Maria Katsara
Lesley Probert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0801424A external-priority patent/GB0801424D0/en
Priority claimed from GB0802405A external-priority patent/GB0802405D0/en
Priority claimed from GR20080100151A external-priority patent/GR1006998B/el
Application filed filed Critical
Publication of PL2240200T3 publication Critical patent/PL2240200T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/10—Animals modified by protein administration, for non-therapeutic purpose
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0325—Animal model for autoimmune diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Rehabilitation Therapy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL09703874.9T 2008-01-25 2009-01-22 Terapeutyczny peptyd zasadowego białka mieliny MBP83-99 wiążący mannan PL2240200T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0801424A GB0801424D0 (en) 2008-01-25 2008-01-25 Therapeutic vaccines
GB0802405A GB0802405D0 (en) 2008-02-08 2008-02-08 Therapeutic vaccines
GR20080100151A GR1006998B (el) 2008-02-29 2008-02-29 Ανοσοκυριαρχοι επιτοποι των μυελινικων πρωτεϊνων mbp, mog και plp συζευγμενοι στην ανηγμενη και οξειδωμενη μαννανη μεσω της γεφυρας [(lys-gly)n] για την θεραπεια της σκληρυνσης κατα πλακας.

Publications (1)

Publication Number Publication Date
PL2240200T3 true PL2240200T3 (pl) 2016-12-30

Family

ID=40785428

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09703874.9T PL2240200T3 (pl) 2008-01-25 2009-01-22 Terapeutyczny peptyd zasadowego białka mieliny MBP83-99 wiążący mannan
PL14156495T PL2737906T3 (pl) 2008-01-25 2009-01-22 Szczepionki terapeutyczne

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL14156495T PL2737906T3 (pl) 2008-01-25 2009-01-22 Szczepionki terapeutyczne

Country Status (15)

Country Link
US (2) US9180174B2 (pl)
EP (2) EP2737906B1 (pl)
AU (1) AU2009207345B2 (pl)
CY (2) CY1117898T1 (pl)
DK (2) DK2240200T3 (pl)
ES (2) ES2585482T3 (pl)
HR (2) HRP20160985T1 (pl)
HU (2) HUE037687T2 (pl)
LT (2) LT2240200T (pl)
NO (1) NO2737906T3 (pl)
PL (2) PL2240200T3 (pl)
PT (2) PT2737906T (pl)
SI (2) SI2240200T1 (pl)
TR (1) TR201807084T4 (pl)
WO (1) WO2009093143A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL398077A1 (pl) * 2012-02-10 2012-08-27 Krzysztof Selmaj Kompozycja farmaceutyczna oraz zastosowanie kompozycji do wytwarzania leku, do podawania naskórnego, do leczenia stwardnienia rozsianego
GR20170100262A (el) * 2017-06-12 2019-03-20 Ιωαννης Μηνα Ματσουκας Κυκλικα πεπτιδικα αναλογα της πρωτεϊνης "ολιγοδενδροκυτταρικη μυελινη" και συζευγματα των για την ανοσοθεραπεια της σκληρυνσης κατα πλακας

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002077025A1 (en) 2001-03-23 2002-10-03 John Matsoukas Peptide analogues of myelin basic protein epitopes in the treatment of experimental autoimmune encephalomyelitis (eae) and multiple sclerosis (ms)
IL146016A0 (en) 2001-10-17 2002-07-25 Yeda Res & Dev Synthetic peptides and dna sequences and compositions comprising them for treatment of multiple sclerosis
US8273357B2 (en) 2004-07-16 2012-09-25 Massachusetts Institute Of Technology Antigen-carbohydrate conjugates
US20070178113A1 (en) * 2005-11-22 2007-08-02 Backstrom B T Superantigen conjugate

Also Published As

Publication number Publication date
WO2009093143A3 (en) 2009-11-12
HRP20160985T1 (hr) 2016-10-21
HUE037687T2 (hu) 2018-09-28
AU2009207345A8 (en) 2013-08-22
SI2240200T1 (sl) 2016-11-30
TR201807084T4 (tr) 2018-06-21
PT2240200T (pt) 2016-08-08
EP2240200B1 (en) 2016-05-04
CY1117898T1 (el) 2017-05-17
HRP20180744T1 (hr) 2018-06-29
HUE029899T2 (en) 2017-04-28
DK2240200T3 (en) 2016-08-22
WO2009093143A2 (en) 2009-07-30
US20110243981A1 (en) 2011-10-06
AU2009207345A1 (en) 2009-07-30
PT2737906T (pt) 2018-05-28
LT2737906T (lt) 2018-06-25
AU2009207345B2 (en) 2013-11-28
EP2737906B1 (en) 2018-02-28
US9180174B2 (en) 2015-11-10
SI2737906T1 (en) 2018-08-31
EP2240200A2 (en) 2010-10-20
LT2240200T (lt) 2016-09-26
NO2737906T3 (pl) 2018-07-28
US20160095935A1 (en) 2016-04-07
DK2737906T3 (en) 2018-05-28
PL2737906T3 (pl) 2018-09-28
EP2737906A1 (en) 2014-06-04
CY1120261T1 (el) 2019-07-10
ES2669516T3 (es) 2018-05-28
ES2585482T3 (es) 2016-10-06

Similar Documents

Publication Publication Date Title
ZA201104497B (en) Peptide therapeutic conjugates and uses thereof
ZA201103493B (en) Combination therapy with peptide epoxyketones
IL213341A0 (en) Dipeptide linked medicinal agents
IL218753A0 (en) Protein arrays and uses thereof
GB0702020D0 (en) Peptides and their use
PL2496596T3 (pl) Peptydy terapeutyczne
IL211670A0 (en) Therapeutic protein formulations
EP2125875A4 (en) THERAPEUTIC PEPTIDES WITH METAL FASTENING
IL203221A (en) Bioactive peptides and antibodies
ZA201305266B (en) Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
GB0702021D0 (en) Peptides and their use
GB0702022D0 (en) Peptides and their use
SI2207790T1 (sl) Biološko aktivni C-terminalni arginin vsebujoči peptidi
IL209595A0 (en) Variant hhip1 protein and methods and uses thereof
IL212078A0 (en) Antibodies to modified human igf-1/e peptides
ZA200908989B (en) Enhancement of the efficacy of therapeutic proteins
GB2460178B (en) Depsipeptides and their therapeutic use
GB2460181B (en) Depsipeptides and their therapeutic use
GB0724953D0 (en) Methods of peptide modification
SI2240200T1 (sl) Terapevtski, z mananom povezan peptid, mileinskega bazičnega proteina MBP83-99
GB0905970D0 (en) Depsipeptides and their therapeutic use
GB0609121D0 (en) Peptide Therapy
GB2460180B (en) Depsipeptides and their therapeutic use
GB0909944D0 (en) Therapeutic agent and assay
ZA201209021B (en) Therapeutic peptide composition and method